UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 113

Sortiert nach

Early-Stage Lung Cancer Diagnosis by Deep Learning-Based Spectroscopic Analysis of Circulating Exosomes

ACS nano, 2020-05, Vol.14 (5), p.5435-5444

2020

Volltextzugriff (PDF)

Efficacy and safety of netupitant/palonosetron in preventing nausea and vomiting in diffuse large B cell lymphoma patients undergoing R-CHOP chemotherapy

Scientific reports, 2024-05, Vol.14 (1), p.11229-11229, Article 11229

2024

Volltextzugriff (PDF)

Cytomegalovirus reactivation under pre-emptive therapy following allogeneic hematopoietic stem cell transplant: Pattern, survival, and risk factors in the Republic of Korea

PloS one, 2023-09, Vol.18 (9), p.e0291268

2023

Volltextzugriff (PDF)

PD-L1 expression in bone marrow plasma cells as a biomarker to predict multiple myeloma prognosis: developing a nomogram-based prognostic model

Scientific reports, 2020-07, Vol.10 (1), p.12641-12641, Article 12641

2020

Volltextzugriff (PDF)

Use of extracellular vesicle microRNA profiles in patients with acute myeloid leukemia for the identification of novel biomarkers

PloS one, 2024-08, Vol.19 (8), p.e0306962

2024

Volltextzugriff (PDF)

Dual size-exclusion chromatography for efficient isolation of extracellular vesicles from bone marrow derived human plasma

Scientific reports, 2021-01, Vol.11 (1), p.217-217, Article 217

2021

Volltextzugriff (PDF)

Etoposide-mediated interleukin-8 secretion from bone marrow stromal cells induces hematopoietic stem cell mobilization

BMC cancer, 2020-07, Vol.20 (1), p.619-15, Article 619

2020

Volltextzugriff (PDF)

A nationwide study of patients with monoclonal gammopathy of undetermined significance with a 10-year follow-up in South Korea

Scientific reports, 2021-09, Vol.11 (1), p.18449-18449, Article 18449

2021

Volltextzugriff (PDF)

Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial

Nature communications, 2024-03, Vol.15 (1), p.2776-2776, Article 2776

2024

Volltextzugriff (PDF)

GCC2 as a New Early Diagnostic Biomarker for Non-Small Cell Lung Cancer

Cancers, 2021-10, Vol.13 (21), p.5482

2021

Volltextzugriff (PDF)

Label-Free CD34+ Cell Identification Using Deep Learning and Lens-Free Shadow Imaging Technology

Biosensors (Basel), 2023-11, Vol.13 (12), p.993

2023

Volltextzugriff (PDF)

CXCR2 inhibition overcomes ponatinib intolerance by eradicating chronic myeloid leukemic stem cells through PI3K/Akt/mTOR and dipeptidylpeptidase Ⅳ (CD26)

Heliyon, 2023-11, Vol.9 (11), p.e22091, Article e22091

2023

Volltextzugriff (PDF)

Generation of human induced iPSC KUMi003-A from acute promyelocytic leukemia (APL) M3

Stem cell research, 2022-08, Vol.63, p.102861-102861, Article 102861

2022

Volltextzugriff (PDF)

Comparison between 5-day decitabine and 7-day azacitidine for lower-risk myelodysplastic syndromes with poor prognostic features: a retrospective multicentre cohort study

Scientific reports, 2020-01, Vol.10 (1), p.39, Article 39

2020

Volltextzugriff (PDF)

Lack of usefulness of computed tomography for surveillance in patients with aggressive non-Hodgkin lymphoma

PloS one, 2018-02, Vol.13 (2), p.e0192656

2018

Volltextzugriff (PDF)

Generation of induced pluripotent stem cell line KUMi002-A with normal karyotype from a patient with Philadelphia chromosome-positive chronic myeloid leukemia

Stem cell research, 2021-08, Vol.55, p.102465-102465, Article 102465

2021

Volltextzugriff (PDF)

Generation of the human pluripotent stem cell lines KUMi005-A from a patients with multiple myeloma

Stem cell research, 2022-12, Vol.65, p.102939-102939, Article 102939

2022

Volltextzugriff (PDF)

Generation of the induced pluripotent stem cell line KUMi001-A carrying the Philadelphia chromosome from a chronic myeloid leukemia patient

Stem cell research, 2021-08, Vol.55, p.102464-102464, Article 102464

2021

Volltextzugriff (PDF)

Single‐dose etoposide is an effective and safe protocol for stem cell mobilization in patients with multiple myeloma

Journal of clinical apheresis, 2019-10, Vol.34 (5), p.579-588

2019

Volltextzugriff (PDF)

Prognostic Value of Galectin-9 Relates to Programmed Death-Ligand 1 in Patients With Multiple Myeloma

Frontiers in oncology, 2021-06, Vol.11, p.669817-669817

2021

Volltextzugriff (PDF)

A human pluripotent stem cell line KUMi004-A generated from a patient with chronic lymphocytic leukemia

Stem cell research, 2022-04, Vol.60, p.102668-102668, Article 102668

2022

Volltextzugriff (PDF)

Generation of an induced pluripotent stem cell line KUMCi001-A from CD34+ bone marrow cells of a patient with acute lymphoblastic leukemia using human placenta-derived cell conditioned medium

Stem cell research, 2020-08, Vol.47, p.101913-101913, Article 101913

2020

Volltextzugriff (PDF)

Generation of a human induced pluripotent stem cell line KUMi006 from a patient with multiple myeloma

Stem cell research, 2022-05, Vol.61, p.102767-102767, Article 102767

2022

Volltextzugriff (PDF)

Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab

Annals of hematology, 2020-07, Vol.99 (7), p.1493-1503

2020

Volltextzugriff (PDF)

Generation of normal induced pluripotent stem cell line KUMCi002-A from bone marrow CD34+ cells of patient with multiple myeloma disease having 13q deletion and IGH translocation

Stem cell research, 2020-12, Vol.49, p.102030-102030, Article 102030

2020

Volltextzugriff (PDF)

1 – 25 von 113

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(110)
Mit Volltextzugriff
(110)

Publikationsform

Artikel
(111)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(72)
Life Sciences & Biomedicine
(50)
Humans
(29)
Hematology
(19)
Oncology
(18)
Multiple Myeloma
(17)
Science & Technology - Other Topics
(16)
Aged
(15)
Female
(15)
Patients
(15)
Physical Sciences
(15)
Male
(14)
Middle Aged
(14)
Lymphoma
(13)
Prognosis
(13)
Adult
(12)
Retrospective Studies
(12)
Cell Biology
(11)
Cell & Tissue Engineering
(10)
Biotechnology & Applied Microbiology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Early-Stage Lung Cancer Diagnosis by Deep Learning-Based Spectroscopic Analysis of Circulating Exosomes

Efficacy and safety of netupitant/palonosetron in preventing nausea and vomiting in diffuse large B cell lymphoma patients undergoing R-CHOP chemotherapy

Cytomegalovirus reactivation under pre-emptive therapy following allogeneic hematopoietic stem cell transplant: Pattern, survival, and risk factors in the Republic of Korea

PD-L1 expression in bone marrow plasma cells as a biomarker to predict multiple myeloma prognosis: developing a nomogram-based prognostic model

Use of extracellular vesicle microRNA profiles in patients with acute myeloid leukemia for the identification of novel biomarkers

Dual size-exclusion chromatography for efficient isolation of extracellular vesicles from bone marrow derived human plasma

Etoposide-mediated interleukin-8 secretion from bone marrow stromal cells induces hematopoietic stem cell mobilization

A nationwide study of patients with monoclonal gammopathy of undetermined significance with a 10-year follow-up in South Korea

Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial

GCC2 as a New Early Diagnostic Biomarker for Non-Small Cell Lung Cancer

Label-Free CD34+ Cell Identification Using Deep Learning and Lens-Free Shadow Imaging Technology

CXCR2 inhibition overcomes ponatinib intolerance by eradicating chronic myeloid leukemic stem cells through PI3K/Akt/mTOR and dipeptidylpeptidase Ⅳ (CD26)

Generation of human induced iPSC KUMi003-A from acute promyelocytic leukemia (APL) M3

Comparison between 5-day decitabine and 7-day azacitidine for lower-risk myelodysplastic syndromes with poor prognostic features: a retrospective multicentre cohort study

Lack of usefulness of computed tomography for surveillance in patients with aggressive non-Hodgkin lymphoma

Generation of induced pluripotent stem cell line KUMi002-A with normal karyotype from a patient with Philadelphia chromosome-positive chronic myeloid leukemia

Generation of the human pluripotent stem cell lines KUMi005-A from a patients with multiple myeloma

Generation of the induced pluripotent stem cell line KUMi001-A carrying the Philadelphia chromosome from a chronic myeloid leukemia patient

Single‐dose etoposide is an effective and safe protocol for stem cell mobilization in patients with multiple myeloma

Prognostic Value of Galectin-9 Relates to Programmed Death-Ligand 1 in Patients With Multiple Myeloma

A human pluripotent stem cell line KUMi004-A generated from a patient with chronic lymphocytic leukemia

Generation of an induced pluripotent stem cell line KUMCi001-A from CD34+ bone marrow cells of a patient with acute lymphoblastic leukemia using human placenta-derived cell conditioned medium

Generation of a human induced pluripotent stem cell line KUMi006 from a patient with multiple myeloma

Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab

Generation of normal induced pluripotent stem cell line KUMCi002-A from bone marrow CD34+ cells of patient with multiple myeloma disease having 13q deletion and IGH translocation

Suchergebnisse filtern